Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.

For earnings history and earnings-related data on Insmed (INSM) click here.